早期の積極的な診察に基づく薬剤師主導の抗凝固剤モデルは,整形外科における手術前静脈血栓塞栓症の管理を最適化します:後回顧的なコホート研究
Yalan Wang1,2, Qian Du1, Songqing Liu1
1Department of Pharmacy, The Third Affiliated Hospital of Chongqing Medical University, 1 Shuanghu Branch Rd, Yubei District, Chongqing, 401120, People's Republic of China.
International journal of clinical pharmacy
|September 3, 2025
まとめ
薬剤師主導の抗凝固薬のモデルは,骨格外科手術患者の静脈血栓塞栓症 (VTE) を有意に減少させた. この積極的なアプローチは,有害事象を増やすことなく,VTEの予防と安全性を改善しました.
科学分野:
- 薬理学について
- 臨床薬局
- トロンボシス 研究
背景:
- 静脈血栓塞栓症 (VTE) は,整形外科手術における流行し,予防可能な合併症である.
- VTE予防のガイドラインの適正でない遵守は,改善された予防戦略を必要とします.
- 薬剤師主導のモデルである薬剤師早期積極的な相談 (PEAC) フレームワークは,VTEの予防の質と安全性を向上させるという見込みを示しています.
研究 の 目的:
- 骨格外科手術患者の静脈血栓塞栓予防と抗凝固質に対する薬剤師主導の臨床医薬品ケア (VTE- CPC) モデルの影響を評価する.
- PEACの枠組みから派生したVTE-CPCモデルの有効性を評価し,VTEの発生率を削減し,予防法を改善する.
主な方法:
- 薬剤師主導の介入 (VTE- CPC) との通常の治療を比較した遡及的なコホート研究.
- 分析のためのバランスのとれたコホート (n=812) を作成するために使用される傾向スコアマッチング (PSM).
- 評価されたアウトカムには,VTEの発生率,薬理学的予防率,投与量の適切性,および安全性エンドポイント (出血,血栓縮小,臓器機能障害) が含まれていた.
主要な成果:
- VTE- CPC群では,VTEの発生率が著しく低かった (3. 74%対7. 53%,p=0. 020).
- 薬剤師による介入はVTEに対する独立した保護因子であった (OR=0. 45, p=0. 015).
- VTE- CPC群では,手術後の予防 (22. 66%対16. 26%,p=0. 027) の割合が高く,副作用の増加は認められませんでした.
結論:
- 薬剤師主導の抗凝固管理モデルは,整形外科における手術後のVTEの発生率を著しく減少させます.
- このモデルは,有害事象を増やすことなく,血栓予防の品質と安全性を向上させます.
- 薬剤師が主導する積極的な戦略は,VTE予防におけるより広範な実施のために支持されています.
関連する概念動画
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Venous Thrombosis IV: Nursing Management
22
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889
Peripheral Artery Disease V: Postoperative Nursing Management
24
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
24
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44


